Blood Cancer Journal : Impact Factor & More
eISSN: 2044-5385pISSN: 2044-5385
Open AccessShare this on:
Key Metrics
CiteScore 
11.8
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.86 5-Year SI
SJR
Q1Oncology
SNIP
2.52
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Blood Cancer Journal
Blood Cancer Journal Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 3790 | USD 4790 | GBP 3290 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Blood Cancer Journal ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Blood Cancer Journal
Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.
- 7 Aug 2026
- Blood cancer journal
Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study
- 6 Aug 2026
- Blood Cancer Journal
Treatment of adult acute lymphoblastic leukemia\u2014a therapeutic revolution in the making
- 5 Aug 2026
- Blood Cancer Journal
Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine
- 30 Jul 2026
- Blood Cancer Journal
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
- 28 Jul 2026
- Blood Cancer Journal
Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
- 27 Jul 2026
- Blood Cancer Journal
Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.
- 7 Aug 2026
- Blood cancer journal
Post-transplant hypomethylating agents plus venetoclax maintenance improves survival in high-risk myeloid malignancies: A matched cohort study
- 6 Aug 2026
- Blood Cancer Journal
Treatment of adult acute lymphoblastic leukemia\u2014a therapeutic revolution in the making
- 5 Aug 2026
- Blood Cancer Journal
Venetoclax, azacitidine, and G-CSF targeting molecular residual disease in CBFB::MYH11 AML resistant to high-dose cytarabine
- 30 Jul 2026
- Blood Cancer Journal
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
- 28 Jul 2026
- Blood Cancer Journal
Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
- 27 Jul 2026
- Blood Cancer Journal
FAQs on Blood Cancer Journal
How long has Blood Cancer Journal been actively publishing? 
What is the publishing frequency of Blood Cancer Journal?
How many articles did Blood Cancer Journal publish last year?
What is the eISSN & pISSN for Blood Cancer Journal?
What is Citescore for Blood Cancer Journal?
What is SNIP score for Blood Cancer Journal?
What is the SJR for Blood Cancer Journal?
Who is the publisher of Blood Cancer Journal?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations